Novo Nordisk acquires Corvidia for $2.1B with an upfront payment of $725M in cash Sofinnova Partners co-founded Corvidia as its sole seed financial investor in 2015 with serial entrepreneur Michael Davidson PARIS, France – June 11, 2020 - Sofinnova Partners, a leading European life sciences venture capital firm...
Funding to support U.S. commercial launch and global expansion February 16, 2021 08:00 AM Eastern Standard Time - DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced the closing of an equity financing in which it raised gross proceeds of US$108 million. Mainstay in...
EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques February 11, 2021 01:00 AM Eastern Standard Time STOCKHOLM--(BUSINESS WIRE)--EnginZym...
The Roche Venture Fund joins international investor syndicate, including co-lead investors Sofinnova Partners and AbbVie Ventures Funds to be used to advance restorative therapy for type 1 diabetes and inflammatory bowel disease Largest international VC-backed Series A financing round for a biotech in Italy to da...
GHENT, Belgium and RESEARCH TRIANGLE PARK, N.C., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Today, Biotalys NV, a transformative food and crop protection company, announces that it has submitted its first protein-based biocontrol, Evoca™, to the Environmental Protection Agency (EPA) in the United States for approval. Pend...
Paris, France & San Francisco, California, USA, January 13th, 2021 - Moon Surgical, formerly MastOR, is delighted to announce the addition of three seasoned medtech executives to the leadership team: Jeffery Alvarez as Chief Operating Officer, David Noonan as Chief Technology Officer, and Nicolas Linard as Head o...
Clichy, France, January 6th, 2021 – CorWave raises 35 million euros to fund the next stages of its development, with the ambition to become a world-class medtech company serving heart failure patients. The capital increase is subscribed by returning investors joined by the EIC Fund, the European Commission's ve...
Collaboration Strengthens Peijia's Position for Competing in a Largely Untapped Market and Supports Global Expansion of HighLife's Technology SUZHOU, China and PARIS, Dec. 20, 2020/PRNewswire/ -- Peijia Medical Ltd (HK Stock Code: 09996) and HighLife SAS, a Paris-based medical device company, focused on the dev...
The U.S. agreement expands Siemens Healthineers respiratory care portfolio to include critical care ventilators NEW YORK, Dec. 15, 2020 /PRNewswire/ -- CorVent Medical, a Coridea portfolio company focused on developing smart, reusable, lifesaving ventilators for critical care, announced today an agreement with...
Sonova invests at €1.70 per share, to hold circa 3.7% stake in Sensorion Companies signed a letter of intent relating to a collaboration to develop new solutions for hearing loss December 15, 2020 01:00 AM Eastern Standard Time MONTPELLIER, France--(BUSINESS WIRE)-- Regulatory News: Sensorion (Paris:ALSEN) (F...
First publication based on Phase III data to document sustained and clinically meaningful bilateral improvement in visual acuity from unilateral injection of a gene therapy Non-human primate study clarifies mechanism behind contralateral effect Paris, France, December 10, 2020, 7:30 am CET – GenSight Biologics ...
© 2020 Sofinnova Partners TERMS AND CONDITIONS